Ascletis-B (01672) spent approximately HKD 1.9327 million to repurchase 200,000 shares on October 31st.
Ka Li Pharmaceutical-B (01672) announced on October 31, 2025 the repurchase of about HK$1.9327 million...
ASCLETIS-B (01672) announced the repurchase of 200,000 shares for approximately HK$1.9327 million on October 31, 2025.
Related Articles
Guosen: The final mindset of asset trend convergence.
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
Guosen: The final mindset of asset trend convergence.
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
